Filter

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 3 of 3 items for :

  • bronchial neuroendocrine carcinoma x
Clear All
Stéphanie Larose Division of Endocrinology, Department of Medicine, Centre hospitalier de l’Université de Montréal (CHUM), Université de Montréal, Montréal, QC, Canada

Search for other papers by Stéphanie Larose in
Google Scholar
PubMed Close
,
Dany Rioux Division of Endocrinology, Department of Medicine, Centre hospitalier universitaire régional, Trois-Rivières, QC, Canada

Search for other papers by Dany Rioux in
Google Scholar
PubMed Close
,
Roula Albadine Department of Pathology, Centre hospitalier de l’Université de Montréal, Université de Montréal (CHUM), Université de Montréal, Montréal, QC, Canada, Montréal, QC, Canada

Search for other papers by Roula Albadine in
Google Scholar
PubMed Close
, and
André Lacroix Division of Endocrinology, Department of Medicine, Centre hospitalier de l’Université de Montréal (CHUM), Université de Montréal, Montréal, QC, Canada

Search for other papers by André Lacroix in
Google Scholar
PubMed Close

. 2020 ). The most common are well-differentiated bronchial NETs and small-cell carcinomas ( Rekhtman 2022 ). We describe a rare case of EAS from a large-cell neuroendocrine carcinoma (LCNEC) ‘with morphologic features of carcinoid tumor’ of the lung

Article Type:
Case Report
DOI:
https://doi.org/10.1530/EO-23-0002
Volume/Issue:
Volume 3: Issue 1
Open access
Syed Ehsanullah Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA
Siteman Cancer Center, St Louis, Missouri, USA

Search for other papers by Syed Ehsanullah in
Google Scholar
PubMed Close
and
Nikolaos A Trikalinos Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA
Siteman Cancer Center, St Louis, Missouri, USA

Search for other papers by Nikolaos A Trikalinos in
Google Scholar
PubMed Close

1), bronchial NETs ( Pelosi et al. 2010 ) (RASSF1A), as well as Merkel cell carcinomas ( Lassacher et al. 2008 ) (RASSF1A). Adrenocortical cancers are generally hypomethylated but there is literature in hypermethylation of CDKN2A and GATA4

Article Type:
Case Report
DOI:
https://doi.org/10.1530/EO-22-0052
Volume/Issue:
Volume 2: Issue 1
Open access
Joel George Hampshire Hospitals NHS Trust, Basingstoke, United Kingdom of Great Britain and Northern Ireland

Search for other papers by Joel George in
Google Scholar
PubMed Close
,
John Ramage Hampshire Hospitals NHS Trust, Basingstoke, United Kingdom of Great Britain and Northern Ireland

Search for other papers by John Ramage in
Google Scholar
PubMed Close
,
Benjamin White Hampshire Hospitals NHS Trust, Basingstoke, United Kingdom of Great Britain and Northern Ireland

Search for other papers by Benjamin White in
Google Scholar
PubMed Close
, and
Rajaventhan Srirajaskanthan Kings Health Partners NET Centre of Excellence, London, United Kingdom of Great Britain and Northern Ireland

Search for other papers by Rajaventhan Srirajaskanthan in
Google Scholar
PubMed Close

tumours (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). There are four grades for NENs: NET G1 (Ki-67 index <3%), NET G2 (Ki-67 index 3–20%), NET G3 (Ki-67 index >20%) and NEC (Ki-67 index >20%). Ki-67 is a prognostic marker ( Foltyn et

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0077
Volume/Issue:
Volume 3: Issue 1
Open access